跳至主要内容
临床试验/NCT01612182
NCT01612182已完成不适用

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Inje University1 个研究点 分布在 1 个国家目标入组 1,289 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,289
试验地点
1
主要终点
The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy

研究概览

简要总结

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The age of patient was between 18 yrs and 79 yrs.
  • The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

排除标准

  • The level of serum albumin was below 2.0 or over 5.0
  • The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
  • The level of Body mass index was below 15 or over 30
  • Pregnancy

结局指标

主要结局

The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy

时间窗: During hospitalization

The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

次要结局

  • The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy(during hospitalization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hoseok Koo

Nephrology division, Department of Internal Medicine

Inje University

研究点 (1)

Loading locations...

相似试验